TTC Oncology2

TTC Oncology2

TTC Oncology developed TTC-352, a small molecule to fight breast cancer

Print
Claim My Business
Form C
View on Wefunder
Security Type
CAFES
Categories
Technology, Financial Services, Healthcare & Medical, Education
Min Investment
$500
Location
Minneapolis, MN
Expected Close Date
April 30, 2023
Target Raise
$50.00K-$1.00M
No. Investors
72
Security Price
$1
Deal Notes

Novel mechanism of action therapy for hormone resistant of breast cancer. Intellectual property protected until 2033. Safe and well tolerated oral capsule therapy. Biomarker that identifies breast cancer that will respond well to TTC-352. Completed first in human clinical trial. Synergistic activity with PI3K inhibitors

Website
ttconcology.com
Number of Employees
1
Cash
$6,196
Revenue
$0
Short Term Debt
$0
Cost of Goods
$0
Long Term Debt
$494,572
Net Income
$-180,341

Company Description

Novel mechanism of action therapy for hormone resistant of breast cancer.
Intellectual property protected until 2033.
Safe and well tolerated oral capsule therapy.
Biomarker that identifies breast cancer that will respond well to TTC-352.
Completed first in human clinical trial.
Synergistic activity with PI3K inhibitors

Deal Notes

Novel mechanism of action therapy for hormone resistant of breast cancer. Intellectual property protected until 2033. Safe and well tolerated oral capsule therapy. Biomarker that identifies breast cancer that will respond well to TTC-352. Completed first in human clinical trial. Synergistic activity with PI3K inhibitors

Amount Raised : $146,100
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

A CAFES (Contract and Future Equity Stake) can convert into different types of equity upon a Triggering Event, such as: common or preferred stock for a corporation, limited partnership interest for a limited partnership and membership interest for a limited liability company. At the time of the Triggering Event, the specific rights and limitations associated with the equity stake being issued to the investors will be determined and disclosed by the Entrepreneur.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment